Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 19,1x - 21,1x | 20,1x |
| Selected Fwd EBITDA Multiple | 10,7x - 11,8x | 11,2x |
| Fair Value | ₹11,62 - ₹31,39 | ₹21,50 |
| Upside | -16,0% - 127,0% | 55,5% |
| Benchmarks | Ticker | Full Ticker |
| Morepen Laboratories Limited | 500288 | BSE:500288 |
| Supriya Lifescience Limited | 543434 | BSE:543434 |
| SMS Pharmaceuticals Limited | 532815 | BSE:532815 |
| Shilpa Medicare Limited | 530549 | BSE:530549 |
| Anuh Pharma Limited | 506260 | BSE:506260 |
| Ind-Swift Limited | 524652 | BSE:524652 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| 500288 | 543434 | 532815 | 530549 | 506260 | 524652 | ||
| BSE:500288 | BSE:543434 | BSE:532815 | BSE:530549 | BSE:506260 | BSE:524652 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 17.0% | 19.9% | 4.9% | 8.9% | 17.1% | 27.6% | |
| 3Y CAGR | 6.3% | 0.5% | -1.1% | 11.1% | 19.5% | 7.8% | |
| Latest Twelve Months | 71.1% | 48.0% | 21.9% | 56.3% | -14.5% | 23.6% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 8.8% | 34.7% | 17.7% | 18.1% | 10.3% | 11.9% | |
| Prior Fiscal Year | 5.9% | 27.8% | 10.4% | 8.2% | 10.1% | 10.8% | |
| Latest Fiscal Year | 9.1% | 30.7% | 16.5% | 20.3% | 11.6% | 11.7% | |
| Latest Twelve Months | 10.3% | 37.5% | 16.6% | 24.6% | 9.7% | 10.4% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.43x | 8.40x | 2.63x | 4.75x | 1.35x | 2.04x | |
| EV / LTM EBITDA | 13.8x | 22.4x | 15.8x | 19.3x | 13.9x | 19.5x | |
| EV / LTM EBIT | 14.7x | 24.1x | 20.7x | 30.9x | 15.8x | 38.6x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 13.8x | 15.8x | 22.4x | ||||
| Historical EV / LTM EBITDA | 18.0x | 23.1x | 33.5x | ||||
| Selected EV / LTM EBITDA | 19.1x | 20.1x | 21.1x | ||||
| (x) LTM EBITDA | 527 | 527 | 527 | ||||
| (=) Implied Enterprise Value | 10,037 | 10,565 | 11,093 | ||||
| (-) Non-shareholder Claims * | (9,546) | (9,546) | (9,546) | ||||
| (=) Equity Value | 490 | 1,019 | 1,547 | ||||
| (/) Shares Outstanding | 54.2 | 54.2 | 54.2 | ||||
| Implied Value Range | 9.05 | 18.81 | 28.56 | ||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 9.05 | 18.81 | 28.56 | 13.83 | |||
| Upside / (Downside) | -34.5% | 36.0% | 106.5% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 500288 | 543434 | 532815 | 530549 | 506260 | 524652 | |
| Enterprise Value | 25,468 | 56,459 | 20,527 | 59,402 | 8,462 | 10,295 | |
| (+) Cash & Short Term Investments | 1,864 | 843 | 91 | 172 | 519 | 688 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (335) | (55) | (2,853) | (4,906) | (141) | (10,235) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 26,998 | 57,247 | 17,764 | 54,668 | 8,840 | 749 | |
| (/) Shares Outstanding | 548.0 | 80.5 | 84.7 | 86.8 | 50.1 | 54.2 | |
| Implied Stock Price | 49.27 | 711.30 | 209.85 | 629.80 | 176.40 | 13.83 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 49.27 | 711.30 | 209.85 | 629.80 | 176.40 | 13.83 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |